Current News QSM Diagnostics signed a national distribution agreement with MWI Animal Health. Posted on January 25, 2024January 25, 2024 by Cort Meyerson 25 Jan Cort Meyerson C2i Genomics (Life Sciences, 19-20 Cohort) will be acquired by Veracyte for up to $95M Strand Therapeutics announced that the FDA approved the initiation of a Phase 1 first-in-human trial for STX-001, a synthetic mRNA technology that expresses IL-12 cytokine directly within the tumor microenvironment.
